Atender Ignacio – uma CRL entrevista

Meet our second disruptor Ignacio Muñoz-Sanjuán. Find out how Ignacio’s work is enabling organizations to develop novel therapies for Huntington’s disease. Through his drug discovery work at CHDI Foundation, a nonprofit organization, Ignacio fuels his motivation to uncover potential treatments and an eventual cure for this crippling transgenerational disease by partnering with multiple organizations with different technical expertise, like Charles River.

Find the link to the interview here

Deixe um comentário

O seu endereço de e-mail não será publicado.

Posts Relacionados

Deixe uma Resposta

pt_BRPortuguese